GC Therapeutics appoints former BlueRock executive Stefan Irion as chief scientific officer

GC Therapeutics announced that Stefan Irion has joined the company as its new chief scientific officer. Irion previously served in the same capacity at BlueRock Therapeutics.

Irion brings experience leading scientific strategy and development programs from his time at BlueRock, where he was responsible for overseeing research initiatives and advancing the pipeline.

The hiring was highlighted in a STAT+ column that tracks recent personnel moves across the pharmaceutical industry, noting the significance of such leadership changes for company direction and innovation.